Cargando…

Evaluation of diagnostic accuracy of 10 serological assays for detection of SARS-CoV-2 antibodies

Antibody detection is essential to establish exposure, infection, and immunity to SARS-CoV-2, as well as to perform epidemiological studies. The worldwide urge for new diagnostic tools to control the pandemic has led to a quick incorporation in clinical practice of the recently developed serological...

Descripción completa

Detalles Bibliográficos
Autores principales: Gutiérrez-Cobos, Ainhoa, Gómez de Frutos, Sara, Domingo García, Diego, Navarro Lara, Eva, Yarci Carrión, Ayla, Fontán García-Rodrigo, Leticia, Fraile Torres, Arturo Manuel, Cardeñoso Domingo, Laura
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7685685/
https://www.ncbi.nlm.nih.gov/pubmed/33236268
http://dx.doi.org/10.1007/s10096-020-04092-3
_version_ 1783613226430234624
author Gutiérrez-Cobos, Ainhoa
Gómez de Frutos, Sara
Domingo García, Diego
Navarro Lara, Eva
Yarci Carrión, Ayla
Fontán García-Rodrigo, Leticia
Fraile Torres, Arturo Manuel
Cardeñoso Domingo, Laura
author_facet Gutiérrez-Cobos, Ainhoa
Gómez de Frutos, Sara
Domingo García, Diego
Navarro Lara, Eva
Yarci Carrión, Ayla
Fontán García-Rodrigo, Leticia
Fraile Torres, Arturo Manuel
Cardeñoso Domingo, Laura
author_sort Gutiérrez-Cobos, Ainhoa
collection PubMed
description Antibody detection is essential to establish exposure, infection, and immunity to SARS-CoV-2, as well as to perform epidemiological studies. The worldwide urge for new diagnostic tools to control the pandemic has led to a quick incorporation in clinical practice of the recently developed serological assays. However, as only few comparative studies have been published, there is a lack of data about the diagnostic accuracy of currently available assays. We evaluated the diagnostic accuracy to detect Ig G, Ig M+A, and/or IgA anti SARS-CoV-2 of 10 different assays: lateral flow card immunoassays, 4 enzyme-linked immunosorbent assay (ELISA), and 3 chemiluminescent particle immunoassays (CMIA). Using reverse transcriptase polymerase chain reaction (RT-PCR) for COVID-19 as gold standard, sensitivity, specificity, PPV, and NPV were determined. Each assay was tested in 2 groups, namely, positive control, formed by 50 sera from 50 patients with SARS-CoV-2 pneumonia with positive RT-PCR; and negative control, formed by 50 sera from 50 patients with respiratory infection non-COVID-19. Sensitivity range of the 10 assays evaluated for patients with positive COVID-19 RT-PCR was 40–77% (65–81% considering IgG plus IgM). Specificity ranged 83–100%. VPP and VPN were respectively 81–100% and 61.6–81%. Among the lateral flow immunoassays, the highest sensitivity and specificity results were found in Wondfo® SARS-CoV-2 Antibody Test. ELISA IgG and IgA from EUROIMMUN® were the most sensitive ELISA. However, poor results were obtained for isolated detection of IgG. We found similar sensitivity for IgG with SARS-CoV-2 for Architect by Abbott® and ELISA by Vircell®. Results obtained varied widely among the assays evaluated. Due to a better specificity, overall diagnostic accuracy of the assays evaluated was higher in case of positive result. On the other side, lack of antibody detection should be taken with care because of the low sensitivity described. Highest diagnostic accuracy was obtained with ELISA and CMIAs, but they last much longer.
format Online
Article
Text
id pubmed-7685685
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-76856852020-11-25 Evaluation of diagnostic accuracy of 10 serological assays for detection of SARS-CoV-2 antibodies Gutiérrez-Cobos, Ainhoa Gómez de Frutos, Sara Domingo García, Diego Navarro Lara, Eva Yarci Carrión, Ayla Fontán García-Rodrigo, Leticia Fraile Torres, Arturo Manuel Cardeñoso Domingo, Laura Eur J Clin Microbiol Infect Dis Original Article Antibody detection is essential to establish exposure, infection, and immunity to SARS-CoV-2, as well as to perform epidemiological studies. The worldwide urge for new diagnostic tools to control the pandemic has led to a quick incorporation in clinical practice of the recently developed serological assays. However, as only few comparative studies have been published, there is a lack of data about the diagnostic accuracy of currently available assays. We evaluated the diagnostic accuracy to detect Ig G, Ig M+A, and/or IgA anti SARS-CoV-2 of 10 different assays: lateral flow card immunoassays, 4 enzyme-linked immunosorbent assay (ELISA), and 3 chemiluminescent particle immunoassays (CMIA). Using reverse transcriptase polymerase chain reaction (RT-PCR) for COVID-19 as gold standard, sensitivity, specificity, PPV, and NPV were determined. Each assay was tested in 2 groups, namely, positive control, formed by 50 sera from 50 patients with SARS-CoV-2 pneumonia with positive RT-PCR; and negative control, formed by 50 sera from 50 patients with respiratory infection non-COVID-19. Sensitivity range of the 10 assays evaluated for patients with positive COVID-19 RT-PCR was 40–77% (65–81% considering IgG plus IgM). Specificity ranged 83–100%. VPP and VPN were respectively 81–100% and 61.6–81%. Among the lateral flow immunoassays, the highest sensitivity and specificity results were found in Wondfo® SARS-CoV-2 Antibody Test. ELISA IgG and IgA from EUROIMMUN® were the most sensitive ELISA. However, poor results were obtained for isolated detection of IgG. We found similar sensitivity for IgG with SARS-CoV-2 for Architect by Abbott® and ELISA by Vircell®. Results obtained varied widely among the assays evaluated. Due to a better specificity, overall diagnostic accuracy of the assays evaluated was higher in case of positive result. On the other side, lack of antibody detection should be taken with care because of the low sensitivity described. Highest diagnostic accuracy was obtained with ELISA and CMIAs, but they last much longer. Springer Berlin Heidelberg 2020-11-24 2021 /pmc/articles/PMC7685685/ /pubmed/33236268 http://dx.doi.org/10.1007/s10096-020-04092-3 Text en © Springer-Verlag GmbH Germany, part of Springer Nature 2020 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Original Article
Gutiérrez-Cobos, Ainhoa
Gómez de Frutos, Sara
Domingo García, Diego
Navarro Lara, Eva
Yarci Carrión, Ayla
Fontán García-Rodrigo, Leticia
Fraile Torres, Arturo Manuel
Cardeñoso Domingo, Laura
Evaluation of diagnostic accuracy of 10 serological assays for detection of SARS-CoV-2 antibodies
title Evaluation of diagnostic accuracy of 10 serological assays for detection of SARS-CoV-2 antibodies
title_full Evaluation of diagnostic accuracy of 10 serological assays for detection of SARS-CoV-2 antibodies
title_fullStr Evaluation of diagnostic accuracy of 10 serological assays for detection of SARS-CoV-2 antibodies
title_full_unstemmed Evaluation of diagnostic accuracy of 10 serological assays for detection of SARS-CoV-2 antibodies
title_short Evaluation of diagnostic accuracy of 10 serological assays for detection of SARS-CoV-2 antibodies
title_sort evaluation of diagnostic accuracy of 10 serological assays for detection of sars-cov-2 antibodies
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7685685/
https://www.ncbi.nlm.nih.gov/pubmed/33236268
http://dx.doi.org/10.1007/s10096-020-04092-3
work_keys_str_mv AT gutierrezcobosainhoa evaluationofdiagnosticaccuracyof10serologicalassaysfordetectionofsarscov2antibodies
AT gomezdefrutossara evaluationofdiagnosticaccuracyof10serologicalassaysfordetectionofsarscov2antibodies
AT domingogarciadiego evaluationofdiagnosticaccuracyof10serologicalassaysfordetectionofsarscov2antibodies
AT navarrolaraeva evaluationofdiagnosticaccuracyof10serologicalassaysfordetectionofsarscov2antibodies
AT yarcicarrionayla evaluationofdiagnosticaccuracyof10serologicalassaysfordetectionofsarscov2antibodies
AT fontangarciarodrigoleticia evaluationofdiagnosticaccuracyof10serologicalassaysfordetectionofsarscov2antibodies
AT frailetorresarturomanuel evaluationofdiagnosticaccuracyof10serologicalassaysfordetectionofsarscov2antibodies
AT cardenosodomingolaura evaluationofdiagnosticaccuracyof10serologicalassaysfordetectionofsarscov2antibodies